Raymond James Financial’s scPharmaceuticals SCPH Stock Holding History

Raymond James Financial’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-74,487	Closed	-$422K	–	5316
2025 Q3	$422K	Buy	74,487 +10	+0%	+$51	﹤0.01%	4223
2025 Q2	$284K	Sell	74,477 -600	-0.8%	-$1.86K	﹤0.01%	4323
2025 Q1	$197K	Sell	75,077 -14,613	-16%	-$47.6K	﹤0.01%	4432
2024 Q4	$318K	Buy	+89,690	New	+$344K	﹤0.01%	4156

Raymond James Financial's SCPH Position: Q4 2025 in Review

Raymond James Financial sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 74,487 shares — an estimated $422K sold.

Raymond James Financial first reported a position in SCPH in Q4 2024 and held it in 4 quarters. The position peaked at $422K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Raymond James Financial reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Raymond James Financial sold 74,487 scPharmaceuticals shares in Q4 2025, an estimated $422K.
Raymond James Financial first reported a position in scPharmaceuticals in Q4 2024 and held it in 4 quarters.
Raymond James Financial's scPharmaceuticals position peaked at $422K in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Raymond James Financial's 13F filing for Q4 2025, filed 18 Feb 2026.